Real-time enrollment status for this kidney disease clinical trial
Current Status
Completed
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT05999747 |
| Recruiting Status | Completed |
| Condition | Kidney Disease |
| Phase | Clinical Trial |
| Target Enrollment | 94 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Astellas Pharma Global Development, Inc. |
| Last Updated on CT.gov | November 5, 2025 (Nov 5, 2025) |
As of March 2, 2026: Clinical trial NCT05999747 is currently completed participants. This clinical trial study for kidney disease is not currently accepting new participants at 11 locations across the United States. The study is sponsored by Astellas Pharma Global Development, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05999747 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05999747 was last updated Nov 5, 2025 (November 5, 2025). HelloStudys verifies this status automatically.